股民索赔

Search documents
浩丰科技、鸿达兴业(002002)股民索赔案持续推进
Xin Lang Cai Jing· 2025-10-09 02:06
上海久诚律师事务所许峰律师提示,浩丰科技(300419)、鸿达兴业(002002)虚假陈述引发的投资者 索赔案还在继续推进,符合条件的投资者建议保持关注。(许峰律师专栏) 许峰律师代理的浩丰科技投资者索赔案已向法院提交立案,目前正在等待法院的下一步安排。 2024年11月6日晚,浩丰科技公告收到证监会北京监管局下发的《行政处罚决定书》,经查明,浩丰科 技违法事实如下: 2020年,浩丰科技与富通时代科技有限公司、上海埃威航空电子有限公司、北京华航无线电测量研究 所、中电科信息产业有限公司、中航空管系统装备有限公司等5家单位开展信息系统集成业务。上述业 务实质为资金融通业务,浩丰科技在上述业务中实际只履行垫资义务,并收取固定利息。浩丰科技未正 确核算上述业务,涉嫌虚增2020年度营业收入7,312.85万元,占公司当年营业收入的11.43%,导致公司 2020年年度报告存在虚假记载。 三、鸿达兴业未及时披露重大诉讼、仲裁及重大担保事项进展情况 (一)鸿达兴业未及时披露重大诉讼、仲裁事项。 许峰律师代理的鸿达兴业投资者索赔案已向法院提交立案,目前正在等待法院的下一步安排,同步也还 在继续接受其他投资者的索赔委托。 ...
国晟科技涉收入成本确认问题,被北京证监局责令改正
Xin Lang Cai Jing· 2025-09-24 06:35
信本股民索赔团队提醒,国晟科技被北京证监局责令改正 ,因此受损的投资者,可通过"新浪股民维权 平台"自愿登记索赔。 维权条件: 登录新浪财经APP 搜索【信披】查看更多考评等级 9月19日,国晟世安科技股份有限公司(以下简称"国晟科技(维权)"或"公司"))发布公告称,公司于 当日收到北京证监局下发的《关于对国晟世安科技股份有限公司、回全福、吴君、高飞、姚麒、张永胜 采取责令改正措施的决定》。上海市信本律师事务所赵敬国律师(执业证号:13101200410820485)提 示,于2023年4月27日-2025年9月19日期间买入且有持仓,无论在2025年9月20日及之后是否卖出的投资 者,或可通过"新浪股民维权平台"自愿登记索赔。 经查,国晟世安科技股份有限公司存在以下问题:1.园林业务以前年度收入成本确认不准确,未在获知 预计总成本变更的部分或全部事实时,及时进行会计估计变更并调整相关收入、成本确认,导致2022年 年报、2023 年半年报和 2023 年年报相关信息披露不准确。2.对外借款未履行审议程序并及时披露, 2023 年子公司将8,750 万元对外借款视为工程预付款,未向公司管理层报告并履行对外借 ...
*ST正平五个交易日内累计涨幅23.55%,此前被处罚正面临股民索赔
Sou Hu Cai Jing· 2025-09-16 04:19
Core Viewpoint - The company, Zhengping Road and Bridge Construction Co., Ltd. (*ST Zhengping*), is facing significant financial and regulatory challenges, including a warning of delisting due to an audit report that could not express an opinion on its 2024 financials, alongside ongoing losses and non-operational fund occupation issues [2][3]. Financial Performance - The company reported a net profit attributable to shareholders of -484 million yuan for 2024 and -88.12 million yuan for the first half of 2025, indicating continued financial distress [2][5]. - Revenue for 2024 was 1.362 billion yuan, which represents a year-on-year decline of 28.53%. For the second quarter of 2025, revenue was 344 million yuan, down 37.77% year-on-year [5]. Regulatory Issues - The company received an administrative penalty from the Qinghai Securities Regulatory Bureau, which included a fine of 1.5 million yuan and warnings to several executives for violations of securities laws [3]. - Investors who suffered losses from April 29, 2022, to January 22, 2024, are eligible to file claims for compensation [3]. Company Background - Zhengping Road and Bridge was established on March 18, 1996, with a registered capital of approximately 699.62 million yuan. The company is primarily engaged in infrastructure construction and related industries [4][5]. - The company has 955 employees and operates 42 subsidiaries, indicating a broad operational footprint [5]. Risk Factors - The company has a high debt ratio, with asset-liability ratios of 90.92%, 90.60%, and 92.22% for the years 2024 and the first half of 2025, suggesting potential liquidity issues [5]. - There are numerous risk alerts associated with the company, including 526 internal risks and 831 external risks, indicating a challenging operational environment [5].
宜通世纪(300310)股民索赔获法院支持,这些股民仍可参与
Sou Hu Cai Jing· 2025-09-15 12:00
Core Viewpoint - The court has supported investors in their claims against Yitong Century Technology Co., Ltd. (stock code: 300310) for securities fraud, allowing eligible investors to participate in the compensation process [1][2]. Summary by Relevant Sections Company Background - Yitong Century completed the acquisition of Beitai Health in October 2016, which became a wholly-owned subsidiary and was included in Yitong's consolidated financial statements [1]. Fraudulent Activities - From May 1 to December 31, 2017, Beitai Health engaged in financial fraud, inflating revenue by 97.34 million yuan, costs by 52.61 million yuan, and total profit by 40.84 million yuan, which represented 3.7%, 9.75%, and 15.67% of Yitong's reported figures for that period, respectively [1]. Legal Proceedings - Investors who purchased Yitong Century stock between April 3, 2018, and November 4, 2022, and held the stock until the market close on November 4, 2022, are eligible to file claims [2]. Successful Cases - Lawyer Wang Jinlong has a history of successful claims for investors in various companies, including Yitong Century, indicating a strong track record in securities fraud cases [3]. Required Documentation for Claims - Investors need to prepare specific documents for the claims process, including a securities account confirmation, a copy of their ID, and relevant signed materials. The lawyer will guide investors through the process without requiring their presence in court [4].
际华集团主力净流出6.63亿元,刚被立案受损股民可预报名挽损
Sou Hu Cai Jing· 2025-08-13 14:43
Group 1 - The core issue is that Jihua Group is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which could lead to legal consequences for the company [2] - On August 12, Jihua Group reported a transaction volume of 3.964 billion yuan, with a net outflow of 663 million yuan from major investors [2] - Investors who suffered losses due to the company's failure to disclose information accurately and timely can seek compensation, specifically those who bought shares between the company's listing and the close on August 8, 2025 [2] Group 2 - The third special meeting of the independent directors of Jihua Group's sixth board was held on April 25, 2025, with all three independent directors present, confirming the legality and validity of the meeting [3] - The meeting unanimously approved several proposals, including those related to the actual and expected amounts of daily related transactions for 2024 and 2025 [3] - Jihua Group has invested in 42 enterprises and participated in 1,364 bidding projects [3]
*ST苏吴股价八连跌停,爱美客解约核心代理
2 1 Shi Ji Jing Ji Bao Dao· 2025-07-23 12:03
Group 1 - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (*ST Suwu) faced its eighth consecutive trading halt on July 23 due to significant operational challenges stemming from a contract termination with its subsidiary REGEN Biotech, Inc. [1] - REGEN Biotech announced on July 18 that it had sent a termination notice to Datuo Medical (Shanghai) Co., Ltd., which will result in the loss of exclusive distribution rights for the AestheFill product in mainland China [1] - The termination of the distribution agreement is expected to lead to a substantial decrease in revenue and profit for *ST Suwu's medical aesthetics segment in the second half of 2025 [1] Group 2 - On July 13, *ST Suwu received a notice from the China Securities Regulatory Commission (CSRC) regarding administrative penalties for inflating revenue, costs, and profits, with false records in annual reports from 2020 to 2023 [2] - The CSRC plans to impose a fine of 10 million yuan and issue warnings to related personnel, which may trigger mandatory delisting due to serious violations of the Shanghai Stock Exchange listing rules [2] - Following the CSRC's notice, *ST Suwu has been placed under a delisting risk warning by the Shanghai Stock Exchange since July 14 [2]
昔日千亿市值房企已退市,泛海控股受损股民可关注索赔
2 1 Shi Ji Jing Ji Bao Dao· 2025-07-18 11:40
Group 1 - The core point of the news is that *ST Pan Hai (stock code: 000046) is facing delisting due to its stock price being below 1 yuan for twenty consecutive trading days, with the delisting effective from February 7, 2024 [1] - On February 6, 2024, *ST Pan Hai's chairman, Luan Xianzhou, received an administrative penalty from the Beijing Securities Regulatory Bureau for insider trading and leaking insider information related to Minsheng Holdings in 2016, resulting in a confiscation of illegal gains amounting to 5.6377 million yuan and a fine three times the illegal gains [1] - Additionally, on February 5, 2024, *ST Pan Hai received a notice from the China Securities Regulatory Commission regarding an investigation into suspected violations of information disclosure laws, which is currently ongoing [1] Group 2 - Investors who purchased *ST Pan Hai shares on or before February 5, 2024, and sold or continued to hold them after February 6, 2024, may be eligible to file for compensation, although final eligibility will be determined by the court [2]
扬子新材董事邵寅生离职,今年一季度公司亏损508万元
2 1 Shi Ji Jing Ji Bao Dao· 2025-07-11 14:54
Core Points - The resignation of director Shao Yinshi from Yangzi New Materials Co., Ltd. due to personal reasons was announced on July 10, 2025 [1] - The company reported a significant decline in its Q1 2025 financial performance, with total revenue of 70.618 million yuan, a year-on-year decrease of 19.11%, and a net profit attributable to shareholders of -4.6539 million yuan, a year-on-year decline of 6.16% [1] - The company faced administrative penalties from the China Securities Regulatory Commission for significant omissions in its annual report, including undisclosed related party fund occupation and false records [2] Financial Performance - As of the end of Q1 2025, Yangzi New Materials had a total revenue of 70.618 million yuan, down 19.11% year-on-year [1] - The net profit attributable to shareholders was -4.6539 million yuan, reflecting a 6.16% decrease compared to the previous year [1] - The company reported a basic earnings per share of -0.01 yuan and a weighted average return on net assets of -1.76% [1] Regulatory Issues - On November 9, 2023, Yangzi New Materials received an administrative penalty decision from the China Securities Regulatory Commission for major omissions in its annual report [2] - The company was found to have inflated its revenue by approximately 137.1 million yuan in 2020, which accounted for about 11% of its annual revenue [2] - Investors who purchased shares between April 29, 2019, and December 29, 2022, may be eligible to file claims for damages [2]
天沃科技成功摘帽,利好受损股民索赔继续进行
2 1 Shi Ji Jing Ji Bao Dao· 2025-06-30 14:43
Group 1 - The core point of the article is that Suzhou Tianwo Technology Co., Ltd. has lifted its delisting risk warning and changed its stock name back to Tianwo Technology, following a significant improvement in its financial performance [1][2] - The company announced a one-day trading suspension on April 14, 2025, with trading resuming on April 15, 2025, and the stock price limit increased from 5% to 10% [1] - After resuming trading, Tianwo Technology experienced consecutive trading limits, achieving a total of 11 trading days with price increases [1] Group 2 - Tianwo Technology's financial performance for the year 2023 includes a revenue of 3.771 billion yuan and a net profit attributable to shareholders of 1.198 billion yuan, while the net asset at the end of 2023 was 114 million yuan [2] - The company faced delisting risk due to negative net assets reported in its 2022 annual report and consecutive years of negative net profit [2] - The company has received 108 litigation claims from minority shareholders, totaling 13.8419 million yuan, along with additional claims from 68 shareholders amounting to 13.7328 million yuan [1][2]
*ST建艺新增涉诉金额超8000万元 曾因信披违规被罚面临股民索赔
Xin Lang Zheng Quan· 2025-06-18 06:15
Group 1 - The company *ST Jianyi disclosed that as of June 17, it has faced new lawsuits and arbitration cases with a total amount exceeding 83.67 million yuan, accounting for approximately 10.42% of its latest audited net assets [3] - The company is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, with a final penalty issued in April 2023 [3][4] - The company has been fined 1.5 million yuan by the Shenzhen Securities Regulatory Bureau for failing to disclose information properly, particularly regarding transactions with subsidiaries of Evergrande Group [3][4] Group 2 - As of the end of 2024, *ST Jianyi's audited net assets are negative, leading to a delisting risk warning from the Shenzhen Stock Exchange [4] - The company has faced continuous operating capability uncertainties, with negative net profits for the last three accounting years [4] - Shareholders may seek compensation due to the company's information disclosure violations, as per the Civil Code and Securities Law [4]